![]() |
市场调查报告书
商品编码
1876620
具备人工智慧分析功能的数位听诊器市场机会、成长驱动因素、产业趋势分析及2025-2034年预测Digital Stethoscope with AI Analysis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球具有人工智慧分析功能的数位听诊器市值为 6,210 万美元,预计到 2034 年将以 5.7% 的复合年增长率增长至 1.065 亿美元。

由于心血管和呼吸系统疾病病例的增加,以及人工智慧的整合应用、远距医疗的蓬勃发展、手持式诊断设备的普及以及对预防性医疗保健的日益重视,市场正在不断扩张。配备人工智慧的数位听诊器为医疗专业人员提供先进的诊断功能,支援疾病早期检测、持续的患者监测以及人工智慧辅助的临床决策。产品包括有管式和无管式两种型号,并提供有线或无线配置,利用云端或设备端人工智慧技术应用于心臟病学、肺病学及其他领域。远距医疗和远距监测计画的激增使得人工智慧听诊器成为远距会诊、慢性病管理和家庭护理的必备工具。透过蓝牙或Wi-Fi进行无线连接,可将资料即时传输到云端平台,使医生能够快速做出明智的决策。声学设计、讯号处理和降噪的创新显着提高了这些设备的可靠性和精确度,使其诊断性能超越了传统听诊器。
| 市场范围 | |
|---|---|
| 起始年份 | 2024 |
| 预测年份 | 2025-2034 |
| 起始值 | 6210万美元 |
| 预测值 | 1.065亿美元 |
| 复合年增长率 | 5.7% |
预计到2034年,无导管听诊器市场将以6.2%的复合年增长率成长,这主要得益于其便携性、无线功能以及与远距医疗和家庭护理计画的兼容性。无导管听诊器在保留传统声学原理的同时,融合了人工智慧分析和数位讯号处理技术,将创新与可靠的音质完美结合。这些设备广泛应用于医院、基层医疗中心和专科诊所,在这些场所,高保真听诊对于准确的心肺诊断至关重要。
2024年,无线数位听诊器市占率达到78.7%,预计在2025年至2034年间将达到8,070万美元。其市场主导地位源于与蓝牙、Wi-Fi和混合连接的无缝集成,从而能够将资料即时传输至云端平台和人工智慧分析系统。这种连接方式可支持远距医疗、远端监测和持续护理,有助于应对日益严重的心血管和肺部疾病负担。
由于北美地区拥有先进的医疗基础设施、创新医疗设备的高普及率以及完善的远距医疗生态系统,预计到2024年,北美带有人工智慧分析功能的数位听诊器市场份额将达到35.5%。心臟衰竭、心律不整、慢性阻塞性肺病和气喘等疾病的高发生率推动了对早期精准诊断工具的需求。包括高保真麦克风、人工智慧听诊演算法、降噪技术和无线连接在内的技术进步,提升了医院、基层医疗机构和家庭护理计画的诊断能力。
全球人工智慧分析数位听诊器市场的主要参与者包括Aevice Health、Ai Health Highway、Eko Health、eKuore Medical、HD Medical、Lapsi Health、M3DICINE、Minttihealth、Sensi Cardiac、Solventum、Sonavi Labs、Steth IO、StethoMe和Thinklabs。这些公司透过在人工智慧演算法、声学工程和无线连接方面的持续创新来巩固其市场地位。他们正与医院和远距医疗服务提供者建立策略合作伙伴关係,以扩大产品应用范围并展示其临床疗效。此外,各公司也积极投资于监管审批和报销支持,以提高产品的可及性和可信度。产品多样化、精准行销活动和用户友好的行动应用程式有助于将设备更好地融入日常医疗护理中。
The Global Digital Stethoscope with AI Analysis Market was valued at USD 62.1 million in 2024 and is estimated to grow at a CAGR of 5.7% to reach USD 106.5 million by 2034.

The market is expanding due to rising cases of cardiovascular and respiratory conditions, coupled with the integration of artificial intelligence, growth in telemedicine, increasing adoption of handheld diagnostic devices, and a stronger emphasis on preventive healthcare. Digital stethoscopes equipped with AI provide advanced diagnostic capabilities for healthcare professionals, supporting early disease detection, ongoing patient monitoring, and AI-assisted clinical decision-making. Products include both tube-type and tubeless models, with wired or wireless configurations, leveraging cloud-based or on-device AI for cardiology, pulmonary, and other applications. The surge in telemedicine and remote monitoring programs has made AI-enabled stethoscopes indispensable for remote consultations, chronic disease management, and home care. Wireless connectivity through Bluetooth or Wi-Fi facilitates real-time data transfer to cloud platforms, allowing physicians to make informed decisions quickly. Innovations in acoustic design, signal processing, and noise reduction have significantly improved the reliability and precision of these devices, surpassing traditional stethoscopes in diagnostic performance.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $62.1 Million |
| Forecast Value | $106.5 Million |
| CAGR | 5.7% |
The tubeless segment is projected to grow at a CAGR of 6.2% through 2034, driven by its portability, wireless functionality, and compatibility with telemedicine and home care programs. Tubeless stethoscopes maintain classical acoustic principles while incorporating AI-powered analysis and digital signal processing, combining innovation with reliable sound quality. These devices are widely adopted in hospitals, primary care centers, and specialty clinics where high-fidelity auscultation is essential for accurate cardiovascular and pulmonary diagnostics.
The wireless digital stethoscope segment held a 78.7% share in 2024 and is expected to reach USD 80.7 million during 2025-2034. Its dominance stems from seamless integration with Bluetooth, Wi-Fi, and hybrid connectivity, enabling real-time data transmission to cloud platforms and AI analytics systems. This connectivity supports telemedicine, remote monitoring, and continuous care, addressing the increasing burden of cardiovascular and pulmonary disorders.
North America Digital Stethoscope with AI Analysis Market held 35.5% share in 2024 owing to advanced healthcare infrastructure, high adoption of innovative medical devices, and a well-established telemedicine ecosystem. The prevalence of heart failure, arrhythmias, COPD, and asthma drives demand for early and accurate diagnostic tools. Technological advances, including high-fidelity microphones, AI auscultation algorithms, noise reduction, and wireless connectivity, enhance diagnostic capabilities across hospitals, primary care facilities, and home care programs.
Key players in the Global Digital Stethoscope with AI Analysis Market include Aevice Health, Ai Health Highway, Eko Health, eKuore Medical, HD Medical, Lapsi Health, M3DICINE, Minttihealth, Sensi Cardiac, Solventum, Sonavi Labs, Steth IO, StethoMe, and Thinklabs. Companies in the Digital Stethoscope with AI Analysis Market are strengthening their position through continuous innovation in AI algorithms, acoustic engineering, and wireless connectivity. They are forming strategic partnerships with hospitals and telemedicine providers to expand adoption and demonstrate clinical efficacy. Firms are also investing in regulatory approvals and reimbursement support to enhance accessibility and credibility. Product diversification, targeted marketing campaigns, and user-friendly mobile applications help increase device integration into routine care.